Ipsogens' comprehensive solutions combine large scale transcriptional profiling platforms, ultra sensitive biochips, state-of-the-art expertise in biostatistics and bioinformatics and a wealth of experience in designing GLP compliant protocols adapted to genomic analysis of preclinical and clinical studies. Applications range from pharmacogenomic consulting to dissection of mechanisms of action, identification of biomarkers of efficacy / toxicity and elucidation of predictive gene signatures to optimise clinical use of anti-cancer drugs and assist in rational clinical trial design.